Contrast unavailability in U.S. harms diagnostic ultrasound

Article

"We have so many CT and MR machines in the U.S. providing quick, easy, and efficient imaging that it's hard for ultrasound to compete, especially when it comes down to physicians' time.

"We have so many CT and MR machines in the U.S. providing quick, easy, and efficient imaging that it's hard for ultrasound to compete, especially when it comes down to physicians' time.

"I don't think any radiologist would be happy to give a final diagnosis on metastatic disease in the liver using CT or MRI without a contrast agent. We do not have the advantage of using contrast agents with ultrasound in this country, since they have not been approved by the FDA.

"Having contrast agents readily available will help improve ultrasound's diagnostic capabilities in many ways, including bedside imaging of patients who cannot be transported. One of the AIUM's new initiatives is to work with the FDA to accelerate the approval process."

-Lennard Greenbaum, M.D., president of the American Institute of Ultrasound in Medicine, speaking at the AIUM meeting in June

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.